Havens Advisors’s Intersect ENT, Inc XENT Stock Holding History

Havens Advisors’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-109,097	Closed	-$3.06M	–	56
2022 Q1	$3.06M	Sell	109,097 -52,103	-32%	-$1.43M	5.61%	6
2021 Q4	$4.4M	Buy	161,200 +70,097	+77%	+$1.9M	5.2%	7
2021 Q3	$2.48M	Buy	+91,103	New	+$2.25M	2.98%	11

Havens Advisors's XENT Position: Q2 2022 in Review

Havens Advisors sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 109,097 shares — an estimated $3.06M sold.

Havens Advisors first reported a position in XENT in Q3 2021 and held it in 3 quarters. The position peaked at $4.4M in Q4 2021. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

Havens Advisors reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
Havens Advisors sold 109,097 Intersect ENT, Inc shares in Q2 2022, an estimated $3.06M.
Havens Advisors first reported a position in Intersect ENT, Inc in Q3 2021 and held it in 3 quarters.
Havens Advisors's Intersect ENT, Inc position peaked at $4.4M in Q4 2021.
0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Havens Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.